More to explore:
Already have an account?
Log in now
Some good-ish news for DSM's CMO business in Q1.
Have been following Warnex for a few years - they've really struggled but this - I think - is positive news.
GMP News: FDA - S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
DSM confirm news that Percivia is to halt product development. DSM and co-owner Crucell couldn't agree on investment plan.
Pharma sales rise 20% in Bangladesh. The Dhaka-based daily Star says the "outlook bright"
This takeover fight is going to get a bit nasty I think.